| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/EXCR.1999.4672 |
| P698 | PubMed publication ID | 10585254 |
| P2093 | author name string | Laín S | |
| Lane DP | |||
| Xirodimas D | |||
| P2860 | cites work | Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity. | Q105148329 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 315-324 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function | |
| P478 | volume | 253 |
| Q44714283 | A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells |
| Q34101383 | A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. |
| Q36023740 | An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells |
| Q21134737 | Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin |
| Q34489581 | Comparative ultrastructure of CRM1-Nucleolar bodies (CNoBs), Intranucleolar bodies (INBs) and hybrid PML/p62 bodies uncovers new facets of nuclear body dynamic and diversity |
| Q40411164 | Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation |
| Q35268497 | Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study |
| Q33835387 | Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex |
| Q28586586 | Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells |
| Q35123468 | Improving cancer therapy by non-genotoxic activation of p53. |
| Q33232670 | Molecular cloning of the rice field eel Nup93 with predominant expression in gonad and kidney |
| Q36066191 | Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway |
| Q38310025 | Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein. |
| Q35058962 | Nuclear transport as a target for cell growth |
| Q79150763 | Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study |
| Q49299822 | Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement |
| Q24305242 | Proteomic analysis of the mammalian nuclear pore complex |
| Q36710840 | Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. |
| Q27674083 | Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia |
| Q96693730 | Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial |
| Q34076012 | Strategies for manipulating the p53 pathway in the treatment of human cancer. |
| Q46668855 | The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. |
| Q34583882 | Therapeutic exploitation of the p53 pathway |
| Q39959148 | Thyroid hormone receptor alpha1 follows a cooperative CRM1/calreticulin-mediated nuclear export pathway. |
| Q80518102 | Transcription - guarding the genome by sensing DNA damage |
| Q24806368 | p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2 |
| Q35871217 | p53 and MDM2 are involved in the regulation of osteocalcin gene expression. |
Search more.